Covered recipient · General Payments record
LAWRENCE B HURWITZ
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2024
$4,178.26
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $670.39 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ITI, Inc. | $353.06 | 4 |
| Teva Pharmaceuticals USA, Inc. | $233.53 | 3 |
| Axsome Therapeutics, Inc. | $83.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | $83.80 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148298330 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $109.60 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143245173 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17.25 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143245176 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $91.45 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143245180 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $134.76 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143245184 | CMS |
| Teva Pharmaceuticals USA, Inc. | $102.67 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151527425 | CMS |
| Teva Pharmaceuticals USA, Inc. | $123.48 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151527371 | CMS |
| Teva Pharmaceuticals USA, Inc. | $7.38 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151527617 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.